Pulsenmore Ltd. PLSM
TASE · Israel · Technology Services
ILA 688.00-29.60 (-4.12%)
Market closed· · ILA · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · ILA · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Pulsenmore (NASDAQ: PLSM) (TASE: PLSM), a healthcare technology company developing self-use ultrasound solutions for remote care, today announced that it has completed the registration of Pulsenmore FC with the MHRA, the UK regulatory authority responsible for medical devices. The registration enables the Company to market the system in the United Kingdom and Northern Ireland, and follows the recent completion of the system's European registration under the Medical Device Regulation (MDR).
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a healthcare technology company developing self-use ultrasound solutions for remote care, today announced that it has completed the CE European registration process for Pulsenmore FC, its home ultrasound system for monitoring follicular development and endometrial thickness during IVF and fertility preservation treatments.
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leading innovator in remote maternal-fetal healthcare and home ultrasound solutions, presents the key operational, commercial, regulatory, and technological achievements as well as financial updates for the six month period ended June 30, 2026.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.